RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNISING GANGLIOSIDE N-GLYCOLIL-GM3 AND USE THEREOF IN THE DIAGNOSIS AND TREATMENT OF TUMORS

摘要

The invention essentially relates to the production of less immunogenic immunoglobulins by means of genetic engineering and, more specifically, to a monoclonal antibody recognising antigens which contain ganglioside N-glycolyl-GM3 but not other N-glycolyl- or N-acetyl-type gangliosides nor sulphated glycolipids. In particular, the invention relates to peptide sequences encoding a recombinant monoclonal antibody against ganglioside N-glycolyl-GM3 or derivative fragments of same. The invention further relates to pharmaceutical compositions containing the aforementioned antibody or fragments thereof and to the diagnostic or therapeutic use of same for breast cancer and melanoma.